Trials / Unknown
UnknownNCT05079373
Study of Neurological Damage From Coronavirus Disease (COVID-19)
Study of Neurological Damage From Coronavirus Disease (COVID-19): Extraction of Quantitative Imaging Biomarkers for the Characterization of Pathological Profiles
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 250 (estimated)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The objective of this study is to support the exploration of the NEURO-COVID-19 database and in particular to carry out the post-treatments necessary to derive quantitative information on the characterization of the lesion load, in particular with regard to of the vascular tree
Conditions
Timeline
- Start date
- 2021-04-01
- Primary completion
- 2022-10-09
- Completion
- 2022-10-31
- First posted
- 2021-10-15
- Last updated
- 2021-11-30
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05079373. Inclusion in this directory is not an endorsement.